Author

A. Baccarini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

B. D. Brown· 3 shared G. Mollaoglu· 2 shared L. Pia· 2 shared M. Dhainaut· 2 shared M. Merad· 2 shared S. R. Nielsen· 2 shared A. Bektesevic· 1 shared A. H. Rahman· 1 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. D. Brown

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting macrophages with CAR-T cells delays solid tumor progression and enhances anti-tumor immunity

A. R. Sanchez-Paulete, J. Mateus-Tique, G. Mollaoglu, S. R. Nielsen, A. Marks, A. Lakshmi, L. Pia, A. Baccarini, M. Merad, B. D. Brown

This study shows that CAR-T cells targeting macrophages delay tumor growth and improve survival in mouse models of solid tumors by enhancing anti-tumor immunity.

bioRxiv · Dec 17, 2021Immunology

Perturb-map enables CRISPR genomics with spatial resolution and identifies regulators of tumor immune composition

M. Dhainaut, S. A. Rose, G. Akturk, A. Wroblewska, E. Sook Park, S. R. Nielsen, M. Buckup, V. Roudko, L. Pia, J. Le Berichel, A. Bektesevic, B. H. Lee, A. Baccarini, N. Bhardwaj, A. H. Rahman, , B. D. Brown

Perturb-map enables spatial CRISPR screening in tumors, identifying genes that regulate immune composition by mapping gene knockouts and their effects on the tumor microenvironment.

bioRxiv · Jul 13, 2021 · PreprintImmunology

P53 is a direct regulator of the immune co-stimulatory molecule CD80

E. Alibo, G. Mollaoglu, M. Dhainaut, R. Zhao, S. Rose, A. Baccarini, R. Parsons, B. D. Brown

This study identifies CD80 as a direct target of P53, showing that P53 loss reduces CD80 expression and impairs T cell priming in colorectal cancer.

bioRxiv · May 24, 2021 · PreprintImmunology